Padula A M, Leister E
Australian Venom Research Unit, Department of Pharmacology and Therapeutics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, 3010, Australia.
Veterinary Specialist Services, Underwood, Queensland, Australia.
Toxicon. 2017 Nov;138:89-97. doi: 10.1016/j.toxicon.2017.08.015. Epub 2017 Aug 19.
This report describes the diagnosis and treatment of 16 confirmed cases of snakebite from the Australian eastern brown snake (Pseudonaja textilis) in dogs and cats. The clinical signs, brown snake venom antigen concentrations, coagulation parameters, and treatment outcomes following administration of an experimental caprylic acid fractionated bivalent whole IgG antivenom are documented. A brown snake venom antigen specific sandwich ELISA was used to retrospectively quantify venom levels in serum and urine. The characteristic clinical signs of envenomation in all cases were neurotoxicity to a variable extent and coagulation disturbances. The median serum venom concentration at presentation was 122 ng/mL and ranged from 1.9 to 3607 ng/mL. The median urine venom concentration at presentation was 55 ng/mL and ranged from 3.3 to 2604 ng/mL. Mechanical ventilation was used to successfully support respiration in three severely paralysed cases for 1-30 h. In four cases where serum samples were available post-antivenom treatment, venom was no longer detectable. Coagulation parameters measured on citrated plasma samples collected prior to antivenom from each case were abnormally prolonged to variable degrees in all cases. Three cases (2 dogs; 1 cat) were euthanized within four hours of presentation for either cost based reasons (2) or poor prognosis (1). One dog developed massive and potentially fatal pulmonary haemorrhage and was euthanazed. In vitro testing of the venom procoagulant neutralising efficacy of the experimental antivenom demonstrated it was 9.6-72 times more effective when compared to two other commercial veterinary antivenom products. This is the first detailed report of a case series of P. textilis envenomation in dogs and cats. The envenomation syndrome in dogs and cats differed to that reported humans, dominated by neurotoxicity and coagulopathy; unlike in humans, where coagulopathy is of primary clinical significance.
本报告描述了16例确诊的犬猫被澳大利亚东部棕蛇(Pseudonaja textilis)咬伤的诊断和治疗情况。记录了给予实验性辛酸分级二价全IgG抗蛇毒血清后的临床症状、棕蛇毒液抗原浓度、凝血参数和治疗结果。使用一种棕色蛇毒抗原特异性夹心酶联免疫吸附测定法(ELISA)回顾性定量血清和尿液中的毒液水平。所有病例中毒的特征性临床症状在不同程度上均为神经毒性和凝血障碍。就诊时血清毒液浓度中位数为122纳克/毫升,范围为1.9至3607纳克/毫升。就诊时尿液毒液浓度中位数为55纳克/毫升,范围为3.3至2604纳克/毫升。在3例严重瘫痪病例中,使用机械通气成功支持呼吸1至30小时。在抗蛇毒血清治疗后有血清样本的4例病例中,毒液不再可检测到。在抗蛇毒血清治疗前从每个病例采集的枸橼酸盐血浆样本上测量的凝血参数在所有病例中均不同程度地异常延长。3例(2只犬;1只猫)因费用原因(2例)或预后不良(1例)在就诊后4小时内实施安乐死。1只犬发生大量且可能致命的肺出血并被实施安乐死。对实验性抗蛇毒血清的毒液促凝中和效力进行的体外测试表明,与其他两种商业兽医抗蛇毒血清产品相比,其效力高9.6至72倍。这是关于犬猫被东部棕蛇咬伤病例系列的首份详细报告。犬猫的中毒综合征与人类报告的不同,以神经毒性和凝血病为主;与人类不同,人类中凝血病具有主要临床意义。